Inventor · disambiguated record
Wilfried Lubisch
Also filed as: LUBISCH WILFRIED · UNGER LILIANE
83 granted patents·16 pending applications·999 citations·filing 1988–2016
99Inventor score
Top patents by PatentIndex Score
99 records- 0193US8350055B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2010·Granted Jan 8, 2013·23 cites·8 claims
- 0293US6696437B1Heterocyclically substituted benzimidazoles, the production and application thereofABBOTT GMBH & CO KG·Filed 2000·Granted Feb 24, 2004·92 cites·22 claims
- 0391US8129389B2Substituted oxindole derivatives, medicaments containing the latter and use thereofLUBISCH WILFRIED·Filed 2006·Granted Mar 6, 2012·19 cites·10 claims
- 0490US8703774B2Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseasesNETZ ASTRID·Filed 2008·Granted Apr 22, 2014·11 cites·17 claims
- 0590US7902379B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2004·Granted Mar 8, 2011·27 cites·4 claims
- 0689US8546401B25,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseasesBRAJE WILFRIED·Filed 2008·Granted Oct 1, 2013·11 cites·25 claims
- 0789US7087637B2Substituted indoles which are PARP inhibitorsBASF AG·Filed 2001·Granted Aug 8, 2006·45 cites·21 claims
- 0888US8815868B2Substituted oxindole derivatives and their use as vasopressin receptor ligandsNETZ ASTRID·Filed 2007·Granted Aug 26, 2014·8 cites·55 claims
- 0987US8859557B2Substituted oxindole derivatives and their use as vasopressin receptor ligandsNETZ ASTRID·Filed 2012·Granted Oct 14, 2014·7 cites·22 claims
- 1087US8703775B2Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnessesOOST THORSTEN·Filed 2008·Granted Apr 22, 2014·10 cites·14 claims
- 1187US7728012B2Carboxamide compounds and their use as calpain inhibitorsABBOTT GMBH & CO KG·Filed 2008·Granted Jun 1, 2010·8 cites·2 claims
- 1287US6903098B1Use of phthalazine derivativesABBOTT GMBH & CO·Filed 2000·Granted Jun 7, 2005·56 cites·19 claims
- 1384US6448271B1Substituted benzimidazoles and their use as parp inhibitorsBASF AG·Filed 1999·Granted Sep 10, 2002·59 cites·20 claims
- 1483US7951807B2Substituted oxindol derivatives and medicaments containing the sameABBOTT GMBH & CO KG·Filed 2005·Granted May 31, 2011·5 cites·7 claims
- 1583US7041675B2Heterocyclic compounds and their use as PARP inhibitorsABBOTT GMBH & CO KG·Filed 2001·Granted May 9, 2006·22 cites·6 claims
- 1682US7956093B2Substituted amides, their preparation and useABBOTT GMBH & CO KG·Filed 2007·Granted Jun 7, 2011·4 cites·2 claims
- 1782US6436925B1Substituted benzamides, their production and their use as cysteine protease inhibitorsABBOTT LAB·Filed 1999·Granted Aug 20, 2002·59 cites·6 claims
- 1881US7799809B2Carboxamide compounds and their use as calpain inhibitorsABBOTT GMBH & CO KG·Filed 2008·Granted Sep 21, 2010·3 cites·2 claims
- 1981US6448254B1Substituted amides, their production and their useABBOTT LAB·Filed 1999·Granted Sep 10, 2002·53 cites·3 claims
- 2081US6436949B1Heterocyclically substituted benzamides and their useABBOTT LAB·Filed 2000·Granted Aug 20, 2002·15 cites·21 claims
- 2179US7803834B2Substituted oxindole derivatives, drugs containing said derivatives and the use thereofABBOTT GMBH & CO KG·Filed 2006·Granted Sep 28, 2010·3 cites·24 claims
- 2279US6562827B1Heterocyclically substituted amides used as calpain inhibitorsABBOTT LAB·Filed 1999·Granted May 13, 2003·50 cites·23 claims
- 2377US8629148B2Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnessesBRAJE WILFRIED·Filed 2008·Granted Jan 14, 2014·2 cites·32 claims
- 2477US6414157B13-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their useABBOTT LAB·Filed 2000·Granted Jul 2, 2002·12 cites·9 claims
- 2577US6103720AKetobenzamides as calpain inhibitorsBASF AG·Filed 1997·Granted Aug 15, 2000·45 cites·4 claims
- 2676US7851463B2Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Dec 14, 2010·2 cites·21 claims
- 2776US7320979B2N-[(piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2004·Granted Jan 22, 2008·7 cites·22 claims
- 2875US6630493B1Heterocyclically substituted amides, their preparation and useBASF AG·Filed 1999·Granted Oct 7, 2003·35 cites·15 claims
- 2975US6509365B12-phenylbenzimidazoles and 2-phenylindoles, and production and use thereofBASF AG·Filed 1999·Granted Jan 21, 2003·37 cites·22 claims
- 3074US9023854B25-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseasesBRAJE WILFRIED·Filed 2008·Granted May 5, 2015·1 cites·34 claims
- 3174US8044079B2Substituted oxindole derivatives, medicaments containing said derivatives and use thereofABBOTT GMBH & CO KG·Filed 2006·Granted Oct 25, 2011·1 cites·17 claims
- 3273US9422264B2Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted Aug 23, 2016·1 cites·21 claims
- 3373US8580842B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themLUBISCH WILFRIED·Filed 2010·Granted Nov 12, 2013·2 cites·5 claims
- 3473US5296485ASubstituted N-phenylpiperidines and drugs therefromBASF AG·Filed 1992·Granted Mar 22, 1994·14 cites·3 claims
- 3572USRE39608ESubstituted benzimidazoles and their use as PARP inhibitorsABBOTT GMBH & CO KG·Filed 1999·Granted May 1, 2007·30 cites·40 claims
- 3671US8202870B2Substituted oxindole derivatives, medicaments containing the latter and use thereofLUBISCH WILFRIED·Filed 2006·Granted Jun 19, 2012·1 cites·5 claims
- 3771US6251917B1Benzamidoaldehydes and their use as cysteine protease inhibitorsBASF AG·Filed 1997·Granted Jun 26, 2001·31 cites·14 claims
- 3870US9487505B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 8, 2016·1 cites·8 claims
- 3969US6277850B1Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonistsABBOTT LAB·Filed 1997·Granted Aug 21, 2001·13 cites·9 claims
- 4067US8119676B2Substituted benzimidazolone derivatives, medicaments comprising them and their useARNDT TORSTEN·Filed 2007·Granted Feb 21, 2012·1 cites·20 claims
- 4167US7781596B1Substituted 2-phenylbenzimidazoles, the production thereof and their useABBOTT LAB·Filed 1999·Granted Aug 24, 2010·26 cites·20 claims
- 4267US6482832B1Heterocyclically substituted amides, their production and their useABBOTT LAB·Filed 1999·Granted Nov 19, 2002·25 cites·18 claims
- 4364US7276500B2Substituted amides, their preparation and useABBOTT GMBH & CO KG·Filed 2003·Granted Oct 2, 2007·1 cites·4 claims
- 4464US6222034B13-substituted pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their useBASF AG·Filed 1997·Granted Apr 24, 2001·23 cites·13 claims
- 4563US2014378471A1Substituted oxindole derivatives and their use as vasopressin receptor ligandsABBOTT GMBH & CO KG·Filed 2014·Application pending·0 cites
- 4662US7723384B2Keto lactam compounds and use thereofABBOTT GMBH & CO KG·Filed 2004·Granted May 25, 2010·1 cites·19 claims
- 4761US4959373ABispidine derivatives as class III antiarrhythmic agentsBASF AG·Filed 1988·Granted Sep 25, 1990·10 cites·11 claims
- 4859US9403796B2Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnessesABBVIE DEUTSCHLAND·Filed 2014·Granted Aug 2, 2016·0 cites·16 claims
- 4959US5714489A2,3(1H,4H)quinoxalinedioneBASF AG·Filed 1995·Granted Feb 3, 1998·6 cites·4 claims
- 5059US2007021607A1Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2006·Application pending·0 cites
Showing the top 50 of 99 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wilfried Lubisch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →